Polymeropoulos Mihael Hristos

Avg. Two Year Performance

503% Avg. Purchase Return
146% Compound
14% Avg. Sale Return
7% Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return(4%)(19%)(27%)1127%503%
Purchase Success Rate0 of 20 of 20 of 21 of 22 of 2
Average Sale Return< 1%7%9%12%14%
Sale Success Rate16 of 2617 of 2617 of 2617 of 2611 of 26

Vanda Pharmaceuticals, Inc.

Drugs » Biotechnology

President and CEO, Director:

Holdings: 1.87M shares

Sentiment

Insider Trading Sentiment: Accumulate

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--